AstraZeneca's Recentin fails lung cancer trial (Reuters) Reuters - AstraZeneca Plc is stopping a clinical trial of Recentin as a treatment for lung cancer after a mid-stage study failed to meet its main goal, although trials in colorectal cancer will move ahead.
Source: news.yahoo.com
# posted by Network @ 2:00 AM
